Japan Animal Referral Medical Center Co., Ltd.

Japan Animal Referral Medical Center Co., Ltd.

TTSE:6039
901.00
JPY
-38.00
(-4.05%)
69.08EPS
15.17P/E
13.54BMarket Cap
Feb 11Next Earn
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
2026 Y
TTM
Revenue per Share
143.2
182.86
181.1
187.42
190.26
212.21
225.14
241.12
251.16
318.11
311.54
407.5
479.14
492.34
Basic EPS, GAAP
8.34
15.02
18.58
19.62
17.53
24.41
25.76
24.15
24.19
31.27
24.6
40.23
64.49
69.08
Free Cash Flow per Basic Share
10.78
-19.23
8.73
-58.42
-37.42
53
37.06
37.16
-3.74
5.67
-11.34
31.56
-82.08
- -
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
4.14
7.77
- -
Book Value per Share
32.91
59.6
85.32
104.96
126.82
151.04
175.99
196.27
215.76
271
289.3
321
377.69
383.59
Tangible Book Value per Share
29.17
56.51
83.32
102.6
124.79
150.37
174.26
195.09
158.56
226.52
247.7
283.9
334.72
333.23
Basic Weighted Avg Shares
10
10
12
12
12
12
12
12
12
12
14
13
13
13
Sales/Revenue/Turnover
1,481
1,894
2,093
2,192
2,259
2,564
2,734
2,848
2,979
3,873
4,270
5,278
6,192
6,363
Operating Margin (%)
7.76
8.45
11.66
13.43
12.39
15.49
15.75
14.24
14.74
14.99
11.64
13.66
18.57
19.5
Depreciation Expense
203
224
212
202
177
224
218
220
241
412
464
571
589
- -
Net Income, GAAP
86
156
215
229
208
295
313
285
287
381
337
521
833
893
Effective Tax Rate (%)
9.12
- -
5.82
14.38
18.04
24.59
30.74
30.78
32.26
28.71
31.36
27.67
27.02
27.49
Profit Margin (%)
5.82
8.21
10.26
10.47
9.21
11.5
11.44
10.01
9.63
9.83
7.9
9.87
13.46
14.03
Working Capital
7
-165
213
-626
418
590
624
543
574
1,127
239
44
-1,627
-1,583
LT Debt
2,172
2,145
2,298
2,130
3,616
3,312
2,893
2,526
3,376
3,393
3,230
2,848
2,477
2,640
Total Equity
362
656
996
1,228
1,528
1,829
2,134
2,336
2,510
3,706
3,811
4,149
4,881
4,958
Return on Invested Capital (%)
- -
- -
6.1
5.73
4.35
5.25
5.25
5.05
4.96
5.77
4.38
6.7
9.27
9.77
Return on Capital (%)
- -
- -
6.82
6
4.32
5.45
5.77
5.38
4.99
5.57
4.56
7.06
9.74
10.16
Return on Common Equity (%)
- -
30.54
26
20.63
15.1
17.57
15.79
12.76
11.84
12.25
8.97
13.09
18.46
19.44

Capital Structure

JPY

•

in mil. unless spec.
Dec'26
Mar'26
Jun'27
ST Debt
713
2,682
2,520
LT Borrowings
2,638
2,477
2,640
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
13
13
13
Market Capitalization
15,186
15,122
13,545

Working Capital

JPY

•

in mil. unless spec.
Dec'26
Mar'26
Jun'27
Total Current Assets
1,831
2,111
1,833
Cash, Cash Equivalents & STI
1,223
1,593
1,254
Accounts Receivable, Net
408
367
395
Inventories
115
93
128
Total Current Liabilities
1,688
3,738
3,416
Payables & Accruals
- -
- -
- -
ST Debt
713
2,682
2,520
Deferred Revenue
- -
- -
- -

Growth Rates

JPY

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
17.8%
16.89%
17.67%
Free Cash Flow
-250.15%
-282.69%
-359.57%
Net Income, GAAP
17.28%
27.26%
59.97%
Sales/Revenue/Turnover
11.79%
17.16%
17.33%
Total Cash Common Dividend
- -
- -
87.3%

Quarterly Revenue

JPY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
1,251
1,318
1,373
1,336
5,278
2026
1,473
1,560
1,626
1,532
6,192
2027
1,644
- -
- -
- -
- -

Quarterly Earnings Per Share

JPY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
7.89
10.82
12.87
8.65
40.23
2026
13.95
18.03
20.27
12.24
64.49
2027
18.55
- -
- -
- -
- -

Quarterly Dividends Per Share

JPY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
- -
- -
- -
- -
4.14
2026
- -
- -
- -
- -
7.77
2027
- -
- -
- -
- -
- -

Company Description

CEO
Hidehiro Hirao
Full Time Employees
328
Sector
Process industries
Industry
Agricultural commodities/Milling
Address
2-5-8 Hisako Kawasaki KN Japan 213-0032
IPO Date
Mar 26, 2015
Business
Japan Animal Referral Medical Center Co., Ltd. (6039.T) owns and operates veterinary hospitals providing advanced secondary medical care for companion animals, primarily dogs and cats, in Japan. The company offers specialized services including diagnostic imaging with CT, MRI, and PET-CT equipment; radiation therapy; surgical interventions for severe conditions; and comprehensive testing and treatment beyond primary care capabilities available at local animal clinics. Its operations emphasize a division-of-labor model with family animal hospitals, serving pet owners across Japan from its headquarters in Kawasaki City, Kanagawa Prefecture, where it was founded in 2005. In recent developments, the company completed an equity buyback program in March 2024, repurchasing 71,300 shares for approximately 139.75 million yen, and announced changes in shareholder stakes, including a reduction in Pilgrim Partners Asia's ownership in associated entity Advanced Animal Healthcare to 11.75% as of early 2025.